IP Library Patent Application 10970763
Patent Application
App. No. 10/970,763

Biuretized isocyanates and blocked biuretized isocyanates

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/970,763
Abstract

The present invention is directed to a biuret group-containing polyisocyanate composition having an isocyanate functionality of at least 4 prepared by a process comprising reacting a polyisocyanate adduct which a) is prepared from an aliphatic and/or cycloaliphatic diisocyanate; b) has an average isocyanate functionality of at least 2.5, and c) contains isocyanurate groups, with a secondary monoamine at an isocyanate to amine equivalent ratio of from about 4:1 to about 14:1 to incorporate biuret groups into said polyisocyanate. The invention is also directed to a blocked biuret group-containing polyisocyanate composition which is prepared by reacting the biuret-containing polyisocyanate with a blocking agent.

Claims (33)

1 . A biuret group-containing polyisocyanate composition having an isocyanate functionality of at least 4 prepared by a process comprising reacting a polyisocyanate adduct which

a) is prepared from 1,6-hexamethylene diisocyanate,

b) has an average isocyanate functionality of at least 2.5, and

c) contains isocyanurate groups,

with a secondary monoamine at an isocyanate to amine equivalent ratio of about 4:1 to about 14:1 to incorporate biuret groups into said polyisocyanate.

2 . The composition of claim 1 , wherein said adduct has an average isocyanate functionality of at least 2.8 and no more than 8.

3 . The composition of claim 2 , wherein said adduct has an average isocyanate functionality of at least 3.0 and no more than 6.

4 . The composition of claim 1 , wherein said adduct has an NCO content of from 10 to 25% by weight.

5 . (canceled)

6 . The composition of claim 1 , wherein said monoamine is of the formula:

(R 1 )(R 2 )NH,

wherein R 1 and R 2 are the same or different and represent an aliphatic hydrocarbon radical containing from 1 to 20 carbon atoms.

7 . The composition of claim 6 , wherein said monoamine is dibutylamine.

8 . A blocked biuret group-containing polyisocyanate composition having an isocyanate functionality of at least 4 prepared by a process comprising

A) reacting a polyisocyanate adduct which

a) is prepared from 1,6-hexamethylene diisocyanate,

b) has an average isocyanate functionality of at least 2.5, and

b) contains isocyanurate groups,

with a secondary monoamine at an isocyanate to amine equivalent ratio of about 4:1 to about 14:1 to incorporate biuret groups into said polyisocyanate, and

B) reacting the biuret-containing polyisocyanate with a blocking agent.

9 . The composition of claim 8 , wherein said adduct has an average isocyanate functionality of at least 2.8 and no more than 8.

10 . The composition of claim 9 , wherein said adduct has an average isocyanate functionality of at least 3.0 and no more than 6.

11 . The composition of claim 8 , wherein said adduct has an NCO content of from 10 to 25% by weight.

12 . (canceled)

13 . The composition of claim 8 , wherein said monoamine is of the formula:

(R 1 )(R 2 )NH,

wherein R 1 and R 2 are the same or different and represent an aliphatic hydrocarbon radical containing from 1 to 20 carbon atoms.

14 . The composition of claim 13 , wherein said monoamine is dibutylamine.

15 . The composition of claim 8 , wherein said blocking agent comprises a member selected from the group consisting of phenol, cresol, aliphatic substituted phenols, amides, oximes, hydrazones, and pyrazoles.

16 . The composition of claim 8 , wherein said blocking agent comprises a member selected from the group consisting of dimethylpyrazole, ε-caprolactam and methyl ethyl ketoxime.

17 . The composition of claim 8 , wherein said blocking agent comprises dimethylpyrazole.

18 . The composition of claim 8 , wherein said blocking agent comprises ε-caprolactam.

19 . The composition of claim 8 , wherein said blocking agent comprises methyl ethyl ketoxime.

Assignments (2)
CHANGE OF NAME Recorded Oct 16, 2015
From: BAYER MATERIALSCIENCE LLC
To: COVESTRO LLC
Reel/Frame 036876/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2004
From: ROESLER, RICHARD R.; BEREZKIN, YULIYA; KINNEY, CAROL L.; MARTIN, KYLI; SHAFFER, MYRON W.
To: BAYER MATERIALSCIENCE LLC
Reel/Frame 016077/0666 →